{"meta":{"query_hash":"ebe2bbe5504d","filters":{"venue":"Nouvelle revue francaise d'hématologie/Blood cells"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ebe2bbe5504d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Nouvelle+revue+francaise+d%27h%C3%A9matologie%2FBlood+cells"},"results":[{"id":"W3120986709","doi":"","title":"A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase","year":2014,"lang":"en","type":"article","venue":"Nouvelle revue francaise d'hématologie/Blood cells","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Enzyme replacement therapy; Adverse effect; Glucocerebrosidase; Clinical trial; Regimen; Pediatrics; Internal medicine; Disease","score_opus":0.021168934135085152,"score_gpt":0.28054792827768776,"score_spread":0.2593789941426026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120986709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723357,0.00052494684,0.00025087115,0.00011961187,0.00004293381,0.0008117004,0.00048562192,0.000029769744,0.00050107326],"genre_scores_gemma":[0.99383485,0.0004848201,0.00094445987,0.0005313978,0.00010302805,0.0014115643,0.0017548407,0.00001865445,0.0009162233],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99951565,0.00018205939,0.00002332755,0.000106529245,0.000054388023,0.00011806622],"domain_scores_gemma":[0.99913675,0.00015534711,0.00018528997,0.00009865559,0.00006623814,0.00035777793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014335649,0.0011785581,0.001618777,0.00030159412,0.00044623433,0.0007412152,0.0005018949,0.0009571348,0.0022859133],"category_scores_gemma":[0.0008983514,0.00033070717,0.0010810349,0.0002975823,0.000881227,0.0008903454,0.00028581396,0.0028823921,0.0004446719],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7890919,0.07222008,0.01855444,0.00040083478,0.0012987517,0.0008110114,0.00056569255,0.0014646692,0.046715707,0.00032821335,0.0028258718,0.06572276],"study_design_scores_gemma":[0.35388467,0.61610323,0.021651534,0.000021671849,0.00029865696,0.00057707116,0.00008929027,0.0009630969,0.0044609383,0.00018820813,0.0017341506,0.000027544324],"about_ca_topic_score_codex":0.0006654626,"about_ca_topic_score_gemma":0.0013354663,"teacher_disagreement_score":0.0022859133,"about_ca_system_score_codex":0.00074908196,"about_ca_system_score_gemma":0.0010861001,"threshold_uncertainty_score":0.0076472163},"labels":[],"label_agreement":null}]}